A recent analysis of the World Health Organizations pharmacovigilance database, VigiBase, found that there was an increased risk of suicidal ideation for patients taking semaglutide, liraglutide, and tirzepatide (Mounjaro, Zepbound) as compared with other medications for diabetes
Set priorities for coverage rather than issuing blanket denials : Instead of wholesale refusals of coverage, policymakers should prioritize individuals who could benefit most from these drugs
In the right patient, the benefits can be substantial, but it should never be a one-size-fits-all approach. Bottom line Ozempic can be a safe and effective medication for adults of all ages, but it hasnt been approved for children and may carry more risks for older adults
Based on these patterns, both body weight and indicators linked to diabetes and heart disease were expected to return to levels seen before treatment within less than two years
Phase 3 data shows up to 71.2 pounds at 68 weeks